We are very glad to announce the first milestone in 2022. Exploration of Targeted Anti-tumor Therapy (ETAT) is now a member of Committee on Publication Ethics (COPE, https://publicationethics.org/)! It signifies that ETAT journal upholds the highest ethical standards and norms. The journal details can be found at: https://members.publicationethics.org/members/exploration-targeted-anti-tumor-therapy

This recognition will provide the most substantial encouragement for ETAT's future development. We really appreciate the efforts of our Editors-in-Chief, Board Members, Guest Editors, authors and reviewers.